A recent study in eClinicalMedicine links tattoo ink exposure to a 21% higher risk of malignant lymphoma, particularly B-cell subtypes. Tattoo ink and laser removal may play significant roles in lymphoma development.
Genprex’s Reqorsa gene therapy picks up orphan drug designation from FDA for SCLC – Pharmaceutical Technology
The market for SCLC treatments is forecasted to reach $2.3bn by 2029. Credit: Shutterstock/Anucha Tiemsom. In another win for Genprex’s Reqorsa immunogene therapy, The US